Cancer
Neoplasm of Uncertain Histogenesis
CI-CAN-00000034Explore in graph →
Non-malignant20,280 active trials259 approved drugs3,813 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00000034Explore in graph →
Clinical trials
91,351 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03235869 | Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma | withdrawn | Early Phase 1 | 0 | University of Michigan Rogel Cancer CenterOTHER | 1 | Mar 15, 2018 | clinicaltrials |
| NCT01933269 | FACBC for Head and Neck Cancers | withdrawn | Early Phase 1 | 0 | Emory UniversityOTHER | 0 | Feb 5, 2018 | clinicaltrials |
| NCT02608736 |
| Chemoprevention of Head and Neck Squamous Cell Carcinoma (HNSCC) With Valproic Acid(GAMA) |
| completed |
| Early Phase 1 |
| 42 |
| Barretos Cancer HospitalOTHER |
| 1 |
| Feb 1, 2018 |
| clinicaltrials |
| NCT02910804 | IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery in Patients With Glioblastoma | unknown | Early Phase 1 | 30 | Beijing Tiantan HospitalOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT01261299 | Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer | terminated | Early Phase 1 | 21 | University of California, DavisOTHER | 1 | Jan 9, 2018 | clinicaltrials |
| NCT01568996 | Pilot Study Evaluating Sulforaphane in Atypical Nevi-Precursor Lesions | completed | Early Phase 1 | 17 | John KirkwoodOTHER | 1 | Jan 9, 2018 | clinicaltrials |
| NCT02077998 | Oxaliplatin in Treating Patients With Metastatic Breast Cancer | completed | Early Phase 1 | 1 | University of California, DavisOTHER | 1 | Jan 9, 2018 | clinicaltrials |
| NCT03385148 | The Clinical Application of 68Ga Labeled ssDNA Aptamer Sgc8 in Healthy Volunteers and Colorectal Patients | unknown | Early Phase 1 | 70 | Xijing HospitalOTHER | 1 | Dec 28, 2017 | clinicaltrials |
| NCT02463383 | Effect of PPARγ2 Polymorphism and NSAIDs on Acute Alcohol-induced Changes in Serum Estrogens Among Post-menopausal Women(EPPNASE) | completed | Early Phase 1 | 25 | Professor Lars Ove DragstedOTHER | 1 | Dec 12, 2017 | clinicaltrials |
| NCT01631331 | Vismodegib in Treating Patients With Basal Cell Carcinoma (BCC) | completed | Early Phase 1 | 15 | Stanford UniversityOTHER | 1 | Dec 8, 2017 | clinicaltrials |
| NCT00972933 | Immunogenicity and Biomarker Analysis of Neoadjuvant Ipilimumab for Melanoma | completed | Early Phase 1 | 59 | Diwakar DavarOTHER | 1 | Dec 7, 2017 | clinicaltrials |
| NCT01867593 | MET-PET for Newly Diagnosed Glioblastoma | completed | Early Phase 1 | 20 | Massachusetts General HospitalOTHER | 1 | Oct 13, 2017 | clinicaltrials |
| NCT00725946 | Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT | terminated | Early Phase 1 | 7 | Stanford UniversityOTHER | 1 | Oct 11, 2017 | clinicaltrials |
| NCT03228303 | Nilotinib Versus Imatinib in Treatment of Patients With Newly Diagnosed Chronic Myeloid Leukemia | unknown | Early Phase 1 | 100 | Assiut UniversityOTHER | 0 | Oct 10, 2017 | clinicaltrials |
| NCT02691169 | Integrated 18F-labelled PSMA Project | unknown | Early Phase 1 | 10 | St. Joseph's Healthcare HamiltonOTHER | 1 | Oct 9, 2017 | clinicaltrials |
| NCT02774512 | Predictive Biomarkers of Biological Activity and Efficacy of Nilotinib on ZAK Target in Non-metastatic Colon Cancer(ZAK-0) | withdrawn | Early Phase 1 | 0 | Institut BergoniéOTHER | 1 | Oct 6, 2017 | clinicaltrials |
| NCT00965003 | MRI Laryngeal Imaging With a Surface Coil | terminated | Early Phase 1 | 3 | Stanford UniversityOTHER | 1 | Oct 5, 2017 | clinicaltrials |
| NCT03288298 | Therapeutic Effect Of Luteolin Natural Extract Versus Its Nanoparticles On Tongue Squamous Cell Carcinoma Cell Line | unknown | Early Phase 1 | 4 | Cairo UniversityOTHER | 0 | Sep 20, 2017 | clinicaltrials |
| NCT02490930 | A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma | completed | Early Phase 1 | 5 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Sep 13, 2017 | clinicaltrials |
| NCT02279992 | Pilot Study of Vardenafil and Carboplatin in Patients With Gliomas and Brain Metastases(LevitraCarbo) | terminated | Early Phase 1 | 7 | Cedars-Sinai Medical CenterOTHER | 1 | Sep 11, 2017 | clinicaltrials |
| NCT01864083 | FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients | completed | Early Phase 1 | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 31, 2017 | clinicaltrials |
| NCT02452216 | Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS | completed | Early Phase 1 | 10 | Michael IvOTHER | 1 | Aug 31, 2017 | clinicaltrials |
| NCT03267173 | Evaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer. | unknown | Early Phase 1 | 10 | First Affiliated Hospital of Harbin Medical UniversityOTHER | 1 | Aug 30, 2017 | clinicaltrials |
| NCT00395109 | PET/CT to Image Hypoxia in Head and Neck Tumours | completed | Early Phase 1 | 17 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Aug 28, 2017 | clinicaltrials |
| NCT01247298 | A Pilot Study of Trans Arterial Chemoembolization (TACE), Followed by Stereotactic Radiation Therapy (SBRT) for Patients With Hepatocellular Carcinoma(RAD 0902) | completed | Early Phase 1 | 17 | University of Alabama at BirminghamOTHER | 1 | Aug 21, 2017 | clinicaltrials |
| NCT02653196 | A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors | terminated | Early Phase 1 | 1 | Montefiore Medical CenterOTHER | 1 | Aug 17, 2017 | clinicaltrials |
| NCT00871533 | Pilot Study of IFN α2b for Melanoma Patients | terminated | Early Phase 1 | 50 | University of PittsburghOTHER | 1 | Aug 4, 2017 | clinicaltrials |
| NCT03070613 | Investigating the Use of Fluorescent Lectins to Identify Dysplasia and Cancer During Endoscopy and Surgery | unknown | Early Phase 1 | 50 | University of OxfordOTHER | 1 | Jul 18, 2017 | clinicaltrials |
| NCT03214939 | Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Colorectal Cancer | unknown | Early Phase 1 | 30 | Research Institute of Fundamental and Clinical ImmunologyOTHER_GOV | 1 | Jul 12, 2017 | clinicaltrials |
| NCT01632696 | Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors | terminated | Early Phase 1 | 11 | Peregrine PharmaceuticalsINDUSTRY | 1 | Jul 11, 2017 | clinicaltrials |
| NCT00020670 | Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia | terminated | Early Phase 1 | 9 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 20, 2017 | clinicaltrials |
| NCT02593929 | Pharmacodynamic Effects and Predictive Biomarkers With Ruxolitinib in Operable Head and Neck Cancer | withdrawn | Early Phase 1 | 0 | University of PittsburghOTHER | 0 | Jun 8, 2017 | clinicaltrials |
| NCT01205672 | Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer | completed | Early Phase 1 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 2, 2017 | clinicaltrials |
| NCT01673802 | The Role of Gadoxetate (Eovist) Enhanced CT in Evaluating Cholangiocarcinoma | completed | Early Phase 1 | 18 | University of Alabama at BirminghamOTHER | 1 | Jun 1, 2017 | clinicaltrials |
| NCT02033447 | Magnetic Nanoparticle Thermoablation-Retention and Maintenance in the Prostate:A Phase 0 Study in Men(MAGNABLATE I) | completed | Early Phase 1 | 12 | University College London HospitalsOTHER | 1 | May 10, 2017 | clinicaltrials |
| NCT01784042 | Dietary Energy Restriction and Omega-3 Fatty Acids on Mammary Tissue | withdrawn | Early Phase 1 | 0 | Milton S. Hershey Medical CenterOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT01034514 | 4D-CT-based Ventilation Imaging for Adaptive Functional Guidance in Radiotherapy | terminated | Early Phase 1 | 35 | Billy W. Loo Jr.OTHER | 1 | May 8, 2017 | clinicaltrials |
| NCT00405366 | Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer(NRR) | completed | Early Phase 1 | 30 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Apr 18, 2017 | clinicaltrials |
| NCT01996527 | 3T MRI Biomarkers of Glioma Treatment Response | terminated | Early Phase 1 | 7 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Apr 17, 2017 | clinicaltrials |
| NCT03113019 | Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Breast Cancer(BC-LDC) | unknown | Early Phase 1 | 26 | Research Institute of Fundamental and Clinical ImmunologyOTHER_GOV | 0 | Apr 13, 2017 | clinicaltrials |
| NCT01527058 | 68Ga-BNOTA-PRGD2 PET/CT in Healthy Volunteers and Lung Cancer Patients(GRGDLC) | unknown | Early Phase 1 | 100 | Peking Union Medical College HospitalOTHER | 1 | Apr 7, 2017 | clinicaltrials |
| NCT01737112 | 99mTc-3PRGD2 SPECT/CT in Lung Cancer Patients(TcRGDLC) | unknown | Early Phase 1 | 100 | Peking Union Medical College HospitalOTHER | 1 | Apr 7, 2017 | clinicaltrials |
| NCT01801371 | 68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma(GRGDG) | unknown | Early Phase 1 | 30 | Peking Union Medical College HospitalOTHER | 1 | Apr 7, 2017 | clinicaltrials |
| NCT02520882 | 68Ga-NOTA-Aca-BBN(7-14) PET/CT in Patients With Primary Gliomas | unknown | Early Phase 1 | 30 | Peking Union Medical College HospitalOTHER | 1 | Apr 7, 2017 | clinicaltrials |
| NCT02278510 | Topotecan Using Convection-Enhanced Delivery (CED) in High Grade Glioma | completed | Early Phase 1 | 3 | Michael Vogelbaum, MD, PhDOTHER | 1 | Mar 31, 2017 | clinicaltrials |
| NCT01050842 | Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancer | completed | Early Phase 1 | 18 | Mayo ClinicOTHER | 1 | Mar 23, 2017 | clinicaltrials |
| NCT01751529 | Open-label Pilot Evaluating Renal Lesions w/ Contrast-enhaced US in Patients w/ Renal Cancer | completed | Early Phase 1 | 48 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Mar 17, 2017 | clinicaltrials |
| NCT00993642 | ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer | withdrawn | Early Phase 1 | 0 | Tulane University Health Sciences CenterOTHER | 1 | Mar 13, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Mar 15, 2018source: clinicaltrials